Exodus Point Capital Management, LP Annexon, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.03 - $7.81 $21,943 - $42,525	5,445 Added 1.76%	315,155 $2.26 Million
Q3 2023 Nov 09, 2023	SELL	$2.13 - $3.84 $62,594 - $112,846	-29,387 Reduced 8.67%	309,710 $731,000
Q2 2023 Aug 10, 2023	BUY	$2.1 - $6.37 $251,976 - $764,329	119,989 Added 54.76%	339,097 $1.19 Million
Q1 2023 May 11, 2023	BUY	$3.74 - $7.46 $303,160 - $604,700	81,059 Added 58.72%	219,108 $844,000
Q4 2022 Feb 13, 2023	BUY	$4.56 - $6.61 $171,296 - $248,304	37,565 Added 37.38%	138,049 $714,000
Q3 2022 Nov 10, 2022	BUY	$3.75 - $6.63 $376,815 - $666,208	100,484 New	100,484 $621,000
Q2 2022 Aug 19, 2022	SELL	$2.11 - $4.06 $38,786 - $74,630	-18,382 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.73 - $11.94 $50,182 - $219,481	18,382 New	18,382 $50,000

146

102M

178K

159K

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $245M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.